Ontology highlight
ABSTRACT:
SUBMITTER: Gallwitz B
PROVIDER: S-EPMC5983089 | biostudies-other | 2014 Aug
REPOSITORIES: biostudies-other
European endocrinology 20140828 2
Safe and effective therapies for type 2 diabetes are needed to reduce the burden of late complications and costs associated with this chronic disease. Hypoglycaemia and body weight gain are side effects and limitations of the therapy with insulin and/or sulphonylureas. Recently, the combination of glucagon-like peptide-1 (GLP-1) receptor agonists and insulin has become available, which is associated with good efficacy and less risk for hypoglycaemia and weight gain. This editorial discusses the ...[more]